Cargando…
Vaccines
Vaccines continue to offer the key line of protection against a range of infectious diseases; however, the range of vaccines currently available is limited. One key consideration in the development of a vaccine is risk-versus-benefit, and in an environment of perceived low risk, the benefit of vacci...
Autores principales: | Perrie, Yvonne, Kaur, Randip, Henriksen-Lacey, Malou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120629/ http://dx.doi.org/10.1007/978-1-4614-9164-4_17 |
Ejemplares similares
-
Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies
por: Henriksen-Lacey, Malou, et al.
Publicado: (2010) -
Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
por: Milicic, Anita, et al.
Publicado: (2012) -
The rational design of vaccines
por: Bramwell, Vincent W., et al.
Publicado: (2005) -
Current Challenges toward In Vitro Cellular Validation
of Inorganic Nanoparticles
por: Henriksen-Lacey, Malou, et al.
Publicado: (2016) -
Immunomic Discovery of Adjuvants, Delivery Systems, and Candidate Subunit Vaccines: A Brief Introduction
por: Flower, Darren R., et al.
Publicado: (2012)